248 related articles for article (PubMed ID: 22265107)
1. Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global review.
Tiggelaar SM; Lin MJ; Viscidi RP; Ji J; Smith JS
J Adolesc Health; 2012 Feb; 50(2):110-31. PubMed ID: 22265107
[TBL] [Abstract][Full Text] [Related]
2. DNA detection and seroprevalence of human papillomavirus in a cohort of adolescent women.
Ermel AC; Shew ML; Weaver BA; Qadadri B; Denski C; Tu W; Tong Y; Fortenberry JD; Brown DR
Sex Transm Infect; 2014 Feb; 90(1):64-9. PubMed ID: 24031030
[TBL] [Abstract][Full Text] [Related]
3. Age-specific prevalence of infection with human papillomavirus in females: a global review.
Smith JS; Melendy A; Rana RK; Pimenta JM
J Adolesc Health; 2008 Oct; 43(4 Suppl):S5-25, S25.e1-41. PubMed ID: 18809145
[TBL] [Abstract][Full Text] [Related]
4. Age-specific prevalence of human papillomavirus infection in males: a global review.
Smith JS; Gilbert PA; Melendy A; Rana RK; Pimenta JM
J Adolesc Health; 2011 Jun; 48(6):540-52. PubMed ID: 21575812
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study.
Dondog B; Clifford GM; Vaccarella S; Waterboer T; Unurjargal D; Avirmed D; Enkhtuya S; Kommoss F; Wentzensen N; Snijders PJ; Meijer CJ; Franceschi S; Pawlita M
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1731-8. PubMed ID: 18628425
[TBL] [Abstract][Full Text] [Related]
6. Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program.
Garland SM; Cornall AM; Brotherton JML; Wark JD; Malloy MJ; Tabrizi SN;
Vaccine; 2018 May; 36(23):3221-3230. PubMed ID: 29724506
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial.
Gray P; Kann H; Pimenoff VN; Eriksson T; Luostarinen T; Vänskä S; Surcel HM; Faust H; Dillner J; Lehtinen M
PLoS Med; 2021 Jun; 18(6):e1003588. PubMed ID: 34097688
[TBL] [Abstract][Full Text] [Related]
8. Oral human papillomavirus infection in men might contribute to HPV serology.
Syrjänen S; Waterboer T; Kero K; Rautava J; Syrjänen K; Grenman S; Pawlita M
Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):237-45. PubMed ID: 25116322
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of Human Papillomavirus (HPV) Type 6, 11, 16, 18, by Anatomic Site of HPV Infection, in Women Aged 16-64 Years living in the Metropolitan Area of San Juan, Puerto Rico.
Pérez-Caraballo AM; Suarez E; Unger ER; Palefsky JM; Panicker G; Ortiz AP
P R Health Sci J; 2018 Mar; 37(1):26-31. PubMed ID: 29547681
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and genotype distribution of HPV infection among 214,715 women from Southern China, 2012-2018: baseline measures prior to mass HPV vaccination.
Luo LP; He P; Liu QT; Jiang YH; Zhang YN; Li QZ; Li Q; Li ST; Yang F; Ling H; Dai XG; Li ZY; Chen HL
BMC Infect Dis; 2021 Apr; 21(1):328. PubMed ID: 33827456
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.
Markowitz LE; Sternberg M; Dunne EF; McQuillan G; Unger ER
J Infect Dis; 2009 Oct; 200(7):1059-67. PubMed ID: 19719390
[TBL] [Abstract][Full Text] [Related]
12. Worldwide impact of the human papillomavirus vaccine.
Hakim AA; Dinh TA
Curr Treat Options Oncol; 2009 Apr; 10(1-2):44-53. PubMed ID: 19387841
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention.
Alemany L; Pérez C; Tous S; Llombart-Bosch A; Lloveras B; Lerma E; Guarch R; Andújar M; Pelayo A; Alejo M; Ordi J; Klaustermeier J; Velasco J; Guimerà N; Clavero O; Castellsagué X; Quint W; Muñoz N; Bosch FX; de Sanjosé S;
Gynecol Oncol; 2012 Mar; 124(3):512-7. PubMed ID: 22119990
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of human papillomavirus types 6, 11, 16 and 18 in young Austrian women - baseline data of a phase III vaccine trial.
Six L; Leodolter S; Sings HL; Barr E; Haupt R; Joura EA
Wien Klin Wochenschr; 2008; 120(21-22):666-71. PubMed ID: 19116707
[TBL] [Abstract][Full Text] [Related]
15. Expanded strain coverage for a highly successful public health tool: Prophylactic 9-valent human papillomavirus vaccine.
Zhang Z; Zhang J; Xia N; Zhao Q
Hum Vaccin Immunother; 2017 Oct; 13(10):2280-2291. PubMed ID: 28699820
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and Safety of a 9-Valent HPV Vaccine.
Van Damme P; Olsson SE; Block S; Castellsague X; Gray GE; Herrera T; Huang LM; Kim DS; Pitisuttithum P; Chen J; Christiano S; Maansson R; Moeller E; Sun X; Vuocolo S; Luxembourg A
Pediatrics; 2015 Jul; 136(1):e28-39. PubMed ID: 26101366
[TBL] [Abstract][Full Text] [Related]
17. Population-Level Herd Protection of Males From a Female Human Papillomavirus Vaccination Program: Evidence from Australian Serosurveillance.
Pillsbury AJ; Quinn HE; Evans TD; McIntyre PB; Brotherton JML
Clin Infect Dis; 2017 Sep; 65(5):827-832. PubMed ID: 29017279
[TBL] [Abstract][Full Text] [Related]
18. Population-based human papillomavirus 16, 18, 6 and 11 DNA positivity and seropositivity in Chinese women.
Smith JS; Lewkowitz AK; Qiao YL; Ji J; Hu S; Chen W; Zhang R; Liaw KL; Esser M; Taddeo FJ; Pretorius RG; Belinson JL
Int J Cancer; 2012 Sep; 131(6):1388-95. PubMed ID: 22120998
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of human papillomavirus type replacement among young pregnant Finnish females before and after a community-randomised HPV vaccination trial with moderate coverage.
Gray P; Kann H; Pimenoff VN; Adhikari I; Eriksson T; Surcel HM; Vänskä S; Dillner J; Faust H; Lehtinen M
Int J Cancer; 2020 Dec; 147(12):3511-3522. PubMed ID: 32574384
[TBL] [Abstract][Full Text] [Related]
20. Predictors of seropositivity to human papillomavirus type 53: one of the most prevalent high risk-related cervical human papillomaviruses.
Malik ZA; Hailpern SM; Burk RD
Viral Immunol; 2008 Sep; 21(3):371-7. PubMed ID: 18681800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
